BPC-157 + TB-500 Stack in Australia: Research Guide

BPC-157 and TB-500 have become the most commonly co-researched peptide combination in musculoskeletal and tissue repair biology. Unlike many peptide combinations studied for additive effects on the same pathway, BPC-157 and TB-500 operate through distinct and complementary mechanisms, making their combination a genuine multi-pathway research tool rather than simple dose stacking.

The combination is sometimes referred to as the "Wolverine stack" in research communities, reflecting the breadth of regenerative pathways it engages. OzPeps stocks a pre-combined BPC-157 / TB-500 blend vial (5mg each) for researchers studying both pathways simultaneously.

BPC-157 (Body Protection Compound-157):

• Stimulates VEGFR2 via the PI3K-Akt-eNOS axis → promotes angiogenesis and new vessel formation at injury sites
• Activates ERK1/2 signalling → enhances fibroblast proliferation and migration
• Modulates the NO (nitric oxide) system → regulates vascular tone and cytoprotection
• Oral stability in gastric environment → unique suitability for GI research models
• Primary research areas: tendon, ligament, muscle, and gastrointestinal repair

TB-500 (Thymosin Beta-4 fragment):

• Sequesters G-actin via LKKTETQ domain → promotes cell motility and migration
• Upregulates matrix metalloproteinases → enables ECM remodelling
• Modulates ILK (integrin-linked kinase) → anti-apoptotic and anti-inflammatory effects
• Systemic distribution → acts at distal sites from the point of administration
• Primary research areas: cardiac repair, systemic tissue regeneration, neural recovery

Preclinical studies examining BPC-157 and TB-500 in combination have reported outcomes exceeding either compound alone in several models:

• Soft tissue repair, combined administration in rodent tendon and muscle injury models has shown accelerated collagen deposition, improved tensile strength, and greater vascularisation at repair sites compared to individual compound controls
• Wound healing, the combination engages both local fibroblast and angiogenic signalling (BPC-157) and systemic keratinocyte and endothelial cell recruitment (TB-500), resulting in more complete repair responses in full-thickness wound models
• Anti-inflammatory synergy, BPC-157 and TB-500 both reduce pro-inflammatory cytokines via different pathways (NO system vs TLR4/MyD88), producing broader inflammatory modulation in combined protocols

The mechanistic rationale is straightforward: BPC-157 handles local vascular and fibroblast recruitment, while TB-500 handles systemic cell mobilisation and migration. Together they address both the local repair environment and the systemic recruitment needed to populate it.

OzPeps' BPC-157 / TB-500 blend vial contains 5mg BPC-157 and 5mg TB-500 (10mg total) in a single lyophilised vial. Reconstitution follows standard protocol, add bacteriostatic water slowly down the inside wall of the vial and swirl gently. TB-500's longer peptide chain (43 amino acids) may require slightly longer dissolution time than BPC-157 alone; gentle warming of the BAC water can assist.

With 2mL bacteriostatic water: concentration = 5mg/mL total (2.5mg/mL each peptide). Use OzPeps' reconstitution calculator for custom volumes. Full reconstitution guide: How to reconstitute peptides →

Pre-combined blend vials offer convenience for researchers running standard combination protocols, but individual vials offer more experimental flexibility:

• Blend vials, fixed 1:1 ratio; convenient for standard combination research; single reconstitution; lower per-mg cost
• Individual vials, adjustable ratios; enables dose-response studies for each compound independently; allows one compound to be varied while the other is held constant

For researchers establishing protocols, individual vials of BPC-157 alongside TB-500 allow ratio optimisation before committing to blend-format procurement.

OzPeps stocks the pre-combined BPC-157 / TB-500 blend and individual BPC-157. View BPC-157 / TB-500 Blend →

All compounds are sold strictly for in-vitro laboratory research purposes. Not TGA-approved. Not for human or animal consumption.